| Literature DB >> 36159548 |
Soo-Hong Kim1, Yong-Hoon Cho1,2, Hae-Young Kim1.
Abstract
BACKGROUND: Spontaneous pneumoperitoneum (SP) without gastrointestinal perforation rarely occurs in neonates, with most SP cases being idiopathic. Although SP usually follows a benign clinical course with favorable prognosis, it can become life-threatening in certain situations. In these cases, urgent surgical intervention may be required. Therefore, it may be difficult to decide when or how to perform prompt interventions. AIM: To demonstrate the distinct clinical features of SP to guide appropriate management by comparing characteristics between SP and typical pneumoperitoneum secondary to gastrointestinal perforation.Entities:
Keywords: Persistent pulmonary hypertension; Pneumothorax; Preterm; Spontaneous pneumoperitoneum; Thrombocytopenia
Year: 2022 PMID: 36159548 PMCID: PMC9403707 DOI: 10.12998/wjcc.v10.i23.8124
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.534
Demographic findings
|
|
|
|
|
| Sex (male/female) | 12/1 | 17/7 | 0.224 |
| GA, wk | 29.5 ± 5.3 (23-39) | 31.7 ± 5.2 (23-39) | 0.216 |
| Preterm/full term | 10/3 (76.9%) | 16/8 (66.7%) | 0.515 |
| Birth weight, g | 1479.2 ± 1071.2 (450-3670) | 1888.2 ± 986.5 (670-3450) | 0.189 |
| Delivery (NSVD/CS) | 1/12 | 10/14 | 0.057 |
| Postnatal age at diagnosis, d | 18.8 ± 29.9 (0-111) | 12.1 ± 18.5 (1~ 79) | 0.499 |
| Apgar at 1 min | 4.0 ± 2.5 (0-8) | 4.3 ± 1.5 (0-8) | 0.936 |
| Apgar at 5 min | 5.8 ± 2.0 (1-9) | 6.5 ± 1.5 (0-9) | 0.825 |
Values are presented as mean ± standard deviation or patient number. GA: Gestational age; NSVD: Normal spontaneous vaginal delivery; CS: Cesarean section.
Figure 1Radiologic findings of pneumoperitoneum. A and B: Spontaneous pneumoperitoneum without gastrointestinal perforation accompanying pneumothorax; C and D: Pneumoperitoneum secondary to gastrointestinal perforation without pneumothorax.
Preceding clinical history before diagnosing a pneumoperitoneum
|
|
|
|
|
|
| MV at birth (yes/no) | 12/1 | 17/7 | 0.216 | 4.333 |
| HFOV (yes/no) | 5/13 | 3/24 | 0.100 | 4.375 |
| PPHN (yes/no) | 7/6 | 2/22 | 0.004 | 12.833 |
| RDS (yes/no) | 11/2 | 15/9 | 0.262 | 3.3 |
| Pneumothorax (yes/no) | 6/7 | 1/23 | 0.004 | 19.7 |
| CPR (yes/no) | 3/10 | 2/22 | 0.321 | 3.3 |
| Vasopressor infusion (yes/no) | 11/2 | 12/12 | 0.074 | 5.5 |
| MV duration, d | 17.1 ± 30.2 (1-111) | 12.4 ± 21.7 (2-79) | 0.067 | - |
Values are presented as patient number or mean ± standard deviation. CI: Confidence intervals; MV: Mechanical ventilation; HFOV: High-frequency oscillation ventilation; PPHN: Persistent pulmonary hypertension; RDS: Respiratory distress syndrome; CPR: Cardiopulmonary resuscitation.
Laboratory findings at diagnosis and outcomes
|
|
|
|
|
| Blood sugar, mg% | 152.1 ± 58.2 (69-235) | 148.3 ± 51.4 (85-294) | 0.790 |
| CRP, IU/L | 1.28 ± 1.60 (0.01-4.88) | 2.24 ± 4.03 (0.03-17.94) | 0.649 |
| WBC, 103/μL | 14641.5 ± 7008.6 (3810-25470) | 14568.8 ± 9349.4 (4410-37360) | 0.561 |
| Segmented neutrophil, % | 57.5 ± 17.4 (20.3-87.0) | 62.1 ± 12.8 (34.1-81.4) | 0.479 |
| PLT, 103/μL | 156.1 ± 115.9 (6.0-371.0) | 272.9 ± 143.8 (83.0-565.0) | 0.015 |
| Thrombocytopenia | 8 / 13 | 5 / 24 | 0.013 |
| pH | 7.26 ± 0.15 (6.95-7.43) | 7.27 ± 0.17 (6.92-7.48) | 0.696 |
| PaO2, mmHg | 55.4 ± 19.2 (18.0-86.8) | 100.9 ± 58.3 (46.3-227.2) | 0.025 |
| Overall mortality, % | 76.9 (10/13) | 16.6 (4/24) | 0.001 |
Values are presented as mean ± standard deviation or patient number. CRP: C-reactive protein; WBC: White blood cell; PLT: Platelet.
Clinical characteristics and analysis of factor affecting mortality in group A, n = 13
|
|
|
|
|
| Management | |||
|
| 5 (38.5) | ||
|
| 8 (61.5) | ||
| Mortality, overall | 10/13 (76.9) | ||
| Mortality in | |||
|
| 5/5 (100) | ||
|
| 5/8 (62.5) | 0.231 | 0.625 (0.365-1.069) |
|
| 6/6 (100) | ||
|
| 4/7 (57.1) | 0.067 | 1.750 (0.921-3.324) |
|
| 6/7 (85.7) | ||
|
| 4/6 (66.7) | 0.416 | 3.0 (0.199-45.244) |
|
| 9/11 (81.8) | ||
|
| 1/2 (50.0) | 0.326 | 4.5 (0.190-106.8) |
|
| 4/5 (80.0) | ||
|
| 6/8 (75.0) | 0.912 | 1.333 (0.088-20.108) |
|
| 9/11 (81.8) | ||
|
| 1/2 (50.0) | 0.326 | 4.5 (0.190-106.823) |
|
| 3/3 (100) | ||
|
| 7/10 (70.0) | 0.279 | 1.429 (0.952-2.143) |
|
| 7/8 (87.5) | ||
|
| 3/5 (60.0) | 0.51 | 4.667 (0.197-73.384) |
|
| 1/3 (33.3) | ||
|
| 9/10 (90.0) | 0.041 | 18.0 (0.758-427.291) |
PPHN: Persistent pulmonary hypertension; RDS: Respiratory distress syndrome; CPR: Cardiopulmonary resuscitation.
Clinical characteristics of Group B, n = 24
|
|
|
| Associated gastrointestinal conditions | |
|
| 7 (29.2) |
|
| 7 (29.2) |
|
| 2 (8.3) |
|
| 4 (16.6) |
|
| 1 (4.2) |
|
| 2 (8.3) |
|
| 1 (4.2) |
| Mortality, overall | 4 (16.6) |
NEC: Necrotizing enterocolitis; SIP: Single intestinal perforation; HD: Hirschsprung disease; EA /c TEF: Esophageal atresia with distal tracheoesophageal fistula.